FIELD: medicine. SUBSTANCE: method involves iodo-antipyrine interferon inductor at a dose of 200 mg/day four times a week during six months. Clinical syndrome manifestations, transaminase concentration are controlled every two weeks. The values becoming normal, the dose is reduced to 100 mg/day 3-4 times a week. EFFECT: enhanced effectiveness of treatment; avoided adverse side effects intrinsic in other interferon preparations. _
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING CHRONIC VIRAL HEPATITIS | 2001 |
|
RU2192881C1 |
METHOD FOR TREATMENT OF CHRONIC HEPATITIS | 2005 |
|
RU2286792C1 |
METHOD FOR TREATING CHRONIC HEPATITIS | 1995 |
|
RU2112535C1 |
METHOD OF TREATING CHRONIC HEPATITIS | 1998 |
|
RU2175237C2 |
INDIVIDUAL SUBSTANCES SYNTHESIZED ON BASE OF CHEMICAL INTERACTION OF DISULFIDE-CONTAINING PEPTIDES WITH PURINE OR PYRIMIDINE BASE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND PREPARATIONS BASED ON THEREOF, METHODS OF THEIR USING FOR TREATMENT OF INFECTIOUS DISEASES AND PROPHYLAXIS OF COMPLICATIONS | 2001 |
|
RU2178710C1 |
METHOD FOR PREDICTION OF ANTIVIRAL THERAPY (AVT) EFFICACY IN CHRONIC HEPATITIS B (CHB) | 2011 |
|
RU2454666C1 |
METHOD FOR DIAGNOSING CHRONIC VIRAL B+C HEPATITIS ON THE OPISTORCHIASIS BACKGROUND | 2002 |
|
RU2226690C2 |
METHOD FOR PREDICTION OF FORMATION OF VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C | 2011 |
|
RU2461834C1 |
METHOD FOR PREDICTING CIRRHOSIS AT CHRONIC VIRAL HEPATITIS | 2003 |
|
RU2244306C1 |
METHOD FOR INDIVIDUAL MATCHING MEDICINAL PREPARATIONS FOR TREATING PATIENTS WITH ETIOLOGICALLY DIFFERENT ACUTE AND CHRONIC VIRAL HEPATITIS | 2002 |
|
RU2222011C1 |
Authors
Dates
2002-03-10—Published
1999-09-03—Filed